2016
DOI: 10.1515/zkri-2016-1931
|View full text |Cite
|
Sign up to set email alerts
|

Crystallographic, DFT and docking (cathepsin B) studies on an organotellurium(IV) compound

Abstract: Some biologically active organotellurium compounds exhibit inhibitory potency against cathepsin B. In this study, an alkyl derivative, viz. [CH

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 42 publications
(50 reference statements)
0
1
0
Order By: Relevance
“…With the aim to understand how potential therapeutic agents based on tellurium inhibit cysteine proteases, significant effort has been made to elucidate their binding modes and correlate them with inhibitory data [47][48][49][50][51]. Continuing this research, the present work targets to explain trends in previous published inhibitory data of a series of halotelluroxetanes, Figure 1, against Cathepsins B, K, L and S. New crystallographic data are presented for 1 and 4, Figure 1, and docking studies of cationic ligands 1ꞌ-4ꞌ, i.e.…”
Section: Decane (1) (3e)-2-chloro-3-(chloromethylidene)-2-(4-methoxymentioning
confidence: 99%
“…With the aim to understand how potential therapeutic agents based on tellurium inhibit cysteine proteases, significant effort has been made to elucidate their binding modes and correlate them with inhibitory data [47][48][49][50][51]. Continuing this research, the present work targets to explain trends in previous published inhibitory data of a series of halotelluroxetanes, Figure 1, against Cathepsins B, K, L and S. New crystallographic data are presented for 1 and 4, Figure 1, and docking studies of cationic ligands 1ꞌ-4ꞌ, i.e.…”
Section: Decane (1) (3e)-2-chloro-3-(chloromethylidene)-2-(4-methoxymentioning
confidence: 99%